Advertisement

Topics

Voyager Therapeutics Inc VYGR Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

01:52 EST 15 Nov 2017 | BioPortfolio Reports

Summary


Voyager Therapeutics Inc Voyager is a gene therapy company that develops treatments for fatal and debilitating diseases of the central nervous system. The company provides treatment for adenoassociated virus gene therapy field by selecting, designing and manufacturing vectors. Its product includes VYAADC01, which is under Phase 1b study, and used for treating Parkinson's disease. Voyager's pipeline products also comprise preclinical programs for amyotrophic lateral sclerosis, Friedreich's ataxia, Huntington's disease and spinal muscular atrophy. It offers high percentage AAV vectors containing therapeutic DNA. The company offers development services in the areas such as vector optimization and engineering, dosing techniques, and process development and production, among others. Voyager is headquartered in Cambridge, Massachusetts, the US.


Voyager Therapeutics Inc Key Recent Developments


Nov 02,2017: Voyager Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Highlights

Sep 18,2017: Voyager Therapeutics Appoints Matthew P. Ottmer as Chief Operating Officer

Aug 08,2017: Voyager Therapeutics Reports Second Quarter 2017 Financial Results and Corporate Highlights

Jul 17,2017: Voyager Therapeutics Announces Publication from the California Institute of Technology of a SecondGeneration Gene Therapy Capsid Demonstrating Further Enhanced Gene Transfer to the Brain

May 09,2017: Voyager Therapeutics Reports First Quarter 2017 Financial Results and Corporate Highlights


This comprehensive SWOT profile of Voyager Therapeutics Inc provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Voyager Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.


The profile contains critical company information including*,


Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Note*: Some sections may be missing if data is unavailable for the company.


Key benefits of buying this profile include,


You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.


Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.


Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.


Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.


Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: Voyager Therapeutics Inc VYGR Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

NEXT ARTICLE

More From BioPortfolio on "Voyager Therapeutics Inc VYGR Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...